Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

569

HTML

3415

Figures (1-3)

193

Tables (1-4)

110

Sum=4287

Mar 21, 2006 (publication date) through Apr 25, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Liver Cancer

World J Gastroenterol. Mar 21, 2006; 12(11): 1699-1705
Published online Mar 21, 2006. doi: 10.3748/wjg.v12.i11.1699

Table 3 Patients with correct diagnosis (existence of metastatic disease) with unenhanced sonography and contrast-enhanced sonography (CEUS)

Citation: Dietrich CF, Kratzer W, Strobel D, Danse E, Fessl R, Bunk A, Vossas U, Hauenstein K, Koch W, Blank W, Oudkerk M, Hahn D, Greis C. Assessment of metastatic liver disease in patients with primary extrahepatic tumors by contrast-enhanced sonography versus CT and MRI. World J Gastroenterol 2006; 12(11): 1699-1705
URL: https://www.wjgnet.com/1007-9327/full/v12/i11/1699.htm
DOI: https://dx.doi.org/10.3748/wjg.v12.i11.1699